Phase 1 study evaluating the association of the cyclin-dependent kinase 4/6 inhibitor ribociclib and cetuximab in recurrent/metastatic p16-negative squamous cell carcinoma of the head and neck

Emmanuel Seront, Sandra Schmitz, Matthias Papier, Aline Van Maanen, Stéphanie Henry, Christophe Lonchay, Sylvie Rottey, Gabrielle Van Caloen, Jean Pascal Machiels

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'Phase 1 study evaluating the association of the cyclin-dependent kinase 4/6 inhibitor ribociclib and cetuximab in recurrent/metastatic p16-negative squamous cell carcinoma of the head and neck'. Together they form a unique fingerprint.

Medicine & Life Sciences